four illustrated demodex mites in front of an eye appear scared of liquid coming out of eye drop bottle

READY TO START ENDING YOUR MITE PARTY?

Here’s How to Get XDEMVY^®

Get the First and Only FDA-Approved Treatment for Demodex Blepharitis (DB)

If you’re experiencing eyelid redness and crusties (collarettes), make an appointment to see an eye doctor and ask them to check for DB. Only an eye doctor can properly diagnose DB.¹
If you are diagnosed with DB, ask your doctor about XDEMVY—the only FDA-approved treatment that targets and kills the Demodex mites that cause DB.^2,3
Our Find a Doctor tool can help you locate an eye doctor in your area who is knowledgeable about Demodex blepharitis (DB). Schedule an appointment today to get your eyelids checked.

Images are character representations of Demodex mites.

Fill out this guide to prepare for a discussion with your eye doctor about DB and see if XDEMVY is right for you.

DB DOCTORS NEAR YOU

Locate DB-knowledgeable eye doctors in your area.

FIND AN EYE DOCTOR

GET MORE WITH XDEMVY

Learn about savings and access to XDEMVY.

ACCESS NOW

illustrated demodex mite standing next to a guide

BROWSE HELPFUL
XDEMVY RESOURCES

Explore the resources library to support your journey.

ACCESS RESOURCES

two illustrated demodex mites are paralyzed one says uh oh in speech bubble with text reading party’s over

References

References: 1. Trattler W, Karpecki P, Rapoport Y, et al. The prevalence of Demodex blepharitis in US eye care clinic patients as determined by collarettes: a pathognomonic sign. Clin Ophthalmol. 2022;16:1153-1164. 2. XDEMVY Pivotal Trial Data Presentation. Tarsus Pharmaceuticals Inc. 3. XDEMVY. Prescribing Information. Tarsus Pharmaceuticals Inc; 2023.

Important Safety Information

Most common side effects: The most common side effect in clinical trials was stinging and burning in 10% of patients. Other side effects in less than 2% of patients were chalazion/hordeolum and punctate keratitis. 

Handling the Container: Avoid allowing the tip of the dispensing container to contact the eye, surrounding structures, fingers, or any other surface in order to minimize contamination of the solution. Serious damage to the eye and subsequent loss of vision may result from using contaminated solutions.

When to Seek Physician Advice: Immediately seek a physician’s advice concerning the continued use of XDEMVY if you develop an intercurrent ocular condition (e.g., trauma or infection), have ocular surgery, or develop any ocular reactions, particularly conjunctivitis and eyelid reactions. 

Use with Contact Lenses: XDEMVY contains potassium sorbate, which may discolor soft contact lenses. Contact lenses should be removed prior to instillation of XDEMVY and may be reinserted 15 minutes following its administration.

To report SUSPECTED ADVERSE REACTIONS, contact Tarsus Pharmaceuticals at 1-888-421-4002 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

READY TO START ENDING YOUR MITE PARTY?

Here’s How to Get XDEMVY®

Get the First and Only FDA-Approved Treatment for Demodex Blepharitis (DB)

DB DOCTORS NEAR YOU

GET MORE WITH XDEMVY

BROWSE HELPFUL XDEMVY RESOURCES

You are leaving the XDEMVY® patient website and going to the Tarsus Pharmaceuticals, Inc. corporate website.

You are leaving the XDEMVY® patient website and going to the healthcare professional website.

You are leaving the XDEMVY® patient website.

Are you a US healthcare professional?

Here’s How to Get XDEMVY^®

BROWSE HELPFUL
XDEMVY RESOURCES

You are leaving the XDEMVY^® patient website and going to the Tarsus Pharmaceuticals, Inc. corporate website.

You are leaving the XDEMVY^® patient website and going to the healthcare professional website.

You are leaving the XDEMVY^® patient website.